Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack Cuzick

Showing results (331-340 of 367) with videos related to

Pageof 37
Sort By:
Cancer Research|January 28, 2010
SOX9 elevation in the prostate promotes proliferation and cooperates with PTEN loss to drive tumor formationMartin K Thomsen, Laurence Ambroisine, Sarah Wynn, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 16, 2023
Breast cancer polygenic risk scores derived in White European populations are not calibrated for women of Ashkenazi Jewish descentEleanor Roberts, Elke M van Veen, Helen Byers, et al.
British Journal of Cancer|March 30, 2016
Breast cancer risk feedback to women in the UK NHS breast screening populationD Gareth R Evans, Louise S Donnelly, Elaine F Harkness, et al.
Epidemiologia E Prevenzione|July 26, 2012
[Health technology assessment report: HPV DNA based primary screening for cervical cancer precursors]Guglielmo Ronco, Annibale Biggeri, Massimo Confortini, et al.
JAMA Oncology|October 4, 2019
A Cost-effectiveness Analysis of Multigene Testing for All Patients With Breast CancerLi Sun, Adam Brentnall, Shreeya Patel, et al.
Nature Reviews. Clinical Oncology|September 2, 2015
HPV-FASTER: broadening the scope for prevention of HPV-related cancerF Xavier Bosch, Claudia Robles, Mireia Díaz, et al.
The Lancet. Oncology|February 12, 2011
Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective studyJack Cuzick, Gregory P Swanson, Gabrielle Fisher, et al.
Breast Cancer Research : BCR|December 3, 2015
Mammographic density adds accuracy to both the Tyrer-Cuzick and Gail breast cancer risk models in a prospective UK screening cohortAdam R Brentnall, Elaine F Harkness, Susan M Astley, et al.
Salud Publica De Mexico|August 25, 2016
Triage strategies in cervical cancer detection in Mexico: methods of the FRIDA StudyLeticia Torres-Ibarra, Eduardo Lazcano-Ponce, Eduardo L Franco, et al.
Journal of the National Cancer Institute|October 1, 2011
Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working groupMitch Dowsett, Torsten O Nielsen, Roger A'Hern, et al.
Pageof 37

Showing results (331-340 of 367) with videos related to

Sort By:
Pageof 37
Cancer Research|January 28, 2010
SOX9 elevation in the prostate promotes proliferation and cooperates with PTEN loss to drive tumor formationMartin K Thomsen, Laurence Ambroisine, Sarah Wynn, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 16, 2023
Breast cancer polygenic risk scores derived in White European populations are not calibrated for women of Ashkenazi Jewish descentEleanor Roberts, Elke M van Veen, Helen Byers, et al.
British Journal of Cancer|March 30, 2016
Breast cancer risk feedback to women in the UK NHS breast screening populationD Gareth R Evans, Louise S Donnelly, Elaine F Harkness, et al.
Epidemiologia E Prevenzione|July 26, 2012
[Health technology assessment report: HPV DNA based primary screening for cervical cancer precursors]Guglielmo Ronco, Annibale Biggeri, Massimo Confortini, et al.
JAMA Oncology|October 4, 2019
A Cost-effectiveness Analysis of Multigene Testing for All Patients With Breast CancerLi Sun, Adam Brentnall, Shreeya Patel, et al.
Nature Reviews. Clinical Oncology|September 2, 2015
HPV-FASTER: broadening the scope for prevention of HPV-related cancerF Xavier Bosch, Claudia Robles, Mireia Díaz, et al.
The Lancet. Oncology|February 12, 2011
Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective studyJack Cuzick, Gregory P Swanson, Gabrielle Fisher, et al.
Breast Cancer Research : BCR|December 3, 2015
Mammographic density adds accuracy to both the Tyrer-Cuzick and Gail breast cancer risk models in a prospective UK screening cohortAdam R Brentnall, Elaine F Harkness, Susan M Astley, et al.
Salud Publica De Mexico|August 25, 2016
Triage strategies in cervical cancer detection in Mexico: methods of the FRIDA StudyLeticia Torres-Ibarra, Eduardo Lazcano-Ponce, Eduardo L Franco, et al.
Journal of the National Cancer Institute|October 1, 2011
Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working groupMitch Dowsett, Torsten O Nielsen, Roger A'Hern, et al.
Pageof 37